CEO of Unilife Alan Shortall describes the company as an advanced drug delivery systems business. Unilife, with Alan Shortall at the helm, has witnessed consistent growth in a short period of time. The process of taking product to market for Unilife, Alan Shortall believes, is “attractive for our shareholders.” Unilife’s Alan Shortall further explains, “The [...]
Unilife Alan Shortall
Unilife Alan Shortall
| Unilife CEO Alan Shortall Unilife Corporation is a U.S. based developer and manufacturer of a diversified portfolio of advanced drug delivery systems. Since CEO and Executive Director Alan Shortall founded Unilife in 2002, he has been a principal driving force behind the company’s rapid global expansion. At Unilife, Alan Shortall has led the Company in the development, patent-protection and diversification of its broad device portfolio, which includes a best-in-class technology platform of safety syringes. As the leader of Unilife, Alan Shortall has also attracted world-class experts from the pharmaceutical and medical device industries to the Board and executive management team. Between 2008 and 2010, Alan Shortall spearheaded Unilife’s transition from Australia to a fully-based and registered U.S. business. This included the redomiciliation of Unilife by Alan Shortall and associates into a Delaware registered Company, and its listing on the NASDAQ stock exchange (NASDAQ:UNIS) in February 2010. Unilife also continues to trade on the Australian Stock Exchange (UNS:ASX). |